A detailed history of Lri Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lri Investments, LLC holds 13,975 shares of ABBV stock, worth $2.52 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
13,975
Previous 9,252 51.05%
Holding current value
$2.52 Million
Previous $1.59 Billion 49.38%
% of portfolio
0.23%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $773,816 - $941,435
4,723 Added 51.05%
13,975 $2.37 Billion
Q2 2024

Jul 24, 2024

BUY
$154.79 - $180.76 $625,661 - $730,631
4,042 Added 77.58%
9,252 $1.59 Billion
Q1 2024

May 21, 2024

SELL
$159.82 - $182.1 $26,689 - $30,410
-167 Reduced 3.11%
5,210 $949 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $859,352 - $979,151
5,377 New
5,377 $867 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.